|
| 36112052 | Contrast Enhancement Patterns in Pediatric Glioblastomas. | J Comput Assist Tomogr | 2023 |
| 36250346 | CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. | Int J Cancer | 2023 |
| 36112052 | Contrast Enhancement Patterns in Pediatric Glioblastomas. | J Comput Assist Tomogr | 2023 |
| 37881491 | TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype <i>in vitro</i>. | Front Oncol | 2023 |
| 37559514 | Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment. | Neuroradiol J | 2023 |
| 37077830 | Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report. | Front Oncol | 2023 |
| 37114244 | Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. | Neurooncol Adv | 2023 |
| 37051329 | Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. | Neurooncol Adv | 2023 |
| 36598462 | Retrospective Analysis of Imaging Characteristics of Tectal Gliomas. | J Comput Assist Tomogr | 2023 |
| 37487571 | Cavernous sinus hemangioma: Histopathological spectrum of 8 cases. | J Neuropathol Exp Neurol | 2023 |
| 36723868 | An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas. | Neuro Oncol | 2023 |
| 37559514 | Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment. | Neuroradiol J | 2023 |
| 37487571 | Cavernous sinus hemangioma: Histopathological spectrum of 8 cases. | J Neuropathol Exp Neurol | 2023 |
| 37881491 | TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype <i>in vitro</i>. | Front Oncol | 2023 |
| 37051329 | Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. | Neurooncol Adv | 2023 |
| 37114244 | Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. | Neurooncol Adv | 2023 |
| 37077830 | Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report. | Front Oncol | 2023 |
| 36723868 | An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas. | Neuro Oncol | 2023 |
| 36598462 | Retrospective Analysis of Imaging Characteristics of Tectal Gliomas. | J Comput Assist Tomogr | 2023 |
| 36250346 | CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. | Int J Cancer | 2023 |
| 35083579 | Long term outcomes following surgery for pineal region tumors. | J Neurooncol | 2022 |
| 35509530 | Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification. | Surg Neurol Int | 2022 |
| 35575067 | A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. | CNS Oncol | 2022 |
| 35426054 | Imaging characteristics of 4th ventricle subependymoma. | Neuroradiology | 2022 |
| 36128585 | Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. | Neurooncol Adv | 2022 |
| 36195959 | Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. | J Exp Clin Cancer Res | 2022 |
| 36526687 | Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion. | Sci Rep | 2022 |
| 36524349 | Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. | Cancer Res | 2022 |
| 35316217 | Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. | JCI Insight | 2022 |
| 34997889 | Final results of the Choroid Plexus Tumor study CPT-SIOP-2000. | J Neurooncol | 2022 |
| 35101778 | Clinical and survival characteristics of primary and secondary gliosarcoma patients. | Clin Neurol Neurosurg | 2022 |
| 35083579 | Long term outcomes following surgery for pineal region tumors. | J Neurooncol | 2022 |
| 35509530 | Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification. | Surg Neurol Int | 2022 |
| 35575067 | A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. | CNS Oncol | 2022 |
| 35426054 | Imaging characteristics of 4th ventricle subependymoma. | Neuroradiology | 2022 |
| 36526687 | Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion. | Sci Rep | 2022 |
| 36524349 | Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. | Cancer Res | 2022 |
| 36128585 | Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. | Neurooncol Adv | 2022 |
| 36195959 | Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. | J Exp Clin Cancer Res | 2022 |
| 35101778 | Clinical and survival characteristics of primary and secondary gliosarcoma patients. | Clin Neurol Neurosurg | 2022 |
| 35316217 | Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. | JCI Insight | 2022 |
| 34997889 | Final results of the Choroid Plexus Tumor study CPT-SIOP-2000. | J Neurooncol | 2022 |
| 33243897 | Estimating Local Cellular Density in Glioma Using MR Imaging Data. | AJNR Am J Neuroradiol | 2021 |
| 33931525 | Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. | Neurology | 2021 |
| 33243897 | Estimating Local Cellular Density in Glioma Using MR Imaging Data. | AJNR Am J Neuroradiol | 2021 |
| 34685601 | Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. | Cells | 2021 |
| 34570201 | Carcinomatosis Encephalitis Secondary to Neuroendocrine Transformation of Prostate Cancer. | JAMA Neurol | 2021 |
| 34377987 | Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. | Neurooncol Adv | 2021 |
| 33931525 | Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. | Neurology | 2021 |
| 34377987 | Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. | Neurooncol Adv | 2021 |